Literature DB >> 9342320

The crystal structure of human interferon beta at 2.2-A resolution.

M Karpusas1, M Nolte, C B Benton, W Meier, W N Lipscomb, S Goelz.   

Abstract

Type I interferons (IFNs) are helical cytokines that have diverse biological activities despite the fact that they appear to interact with the same receptor system. To achieve a better understanding of the structural basis for the different activities of alpha and beta IFNs, we have determined the crystal structure of glycosylated human IFN-beta at 2.2-A resolution by molecular replacement. The molecule adopts a fold similar to that of the previously determined structures of murine IFN-beta and human IFN-alpha2b but displays several distinct structural features. Like human IFN-alpha2b, human IFN-beta contains a zinc-binding site at the interface of the two molecules in the asymmetric unit, raising the question of functional relevance for IFN-beta dimers. However, unlike the human IFN-alpha2b dimer, in which homologous surfaces form the interface, human IFN-beta dimerizes with contact surfaces from opposite sides of the molecule. The relevance of the structure to the effects of point mutations in IFN-beta at specific exposed residues is discussed. A potential role of ligand-ligand interactions in the conformational assembly of IFN receptor components is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342320      PMCID: PMC23607          DOI: 10.1073/pnas.94.22.11813

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.

Authors:  P N Redlich; P D Hoeprich; C B Colby; S E Grossberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography.

Authors:  R Radhakrishnan; L J Walter; A Hruza; P Reichert; P P Trotta; T L Nagabhushan; M R Walter
Journal:  Structure       Date:  1996-12-15       Impact factor: 5.006

3.  Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor.

Authors:  M R Walter; W T Windsor; T L Nagabhushan; D J Lundell; C A Lunn; P J Zauodny; S K Narula
Journal:  Nature       Date:  1995-07-20       Impact factor: 49.962

Review 4.  Structural, functional and evolutionary implications of the three-dimensional crystal structure of murine interferon-beta.

Authors:  Y Mitsui; T Senda; T Shimazu; S Matsuda; J Utsumi
Journal:  Pharmacol Ther       Date:  1993       Impact factor: 12.310

5.  Molecular weight of the functional unit of human leukocyte, fibroblast, and immune interferons.

Authors:  S Pestka; B Kelder; P C Familletti; J A Moschera; R Crowl; E S Kempner
Journal:  J Biol Chem       Date:  1983-08-25       Impact factor: 5.157

6.  Dimeric association and segmental variability in the structure of human CD4.

Authors:  H Wu; P D Kwong; W A Hendrickson
Journal:  Nature       Date:  1997-05-29       Impact factor: 49.962

7.  Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

Authors:  S N Constantinescu; E Croze; A Murti; C Wang; L Basu; D Hollander; D Russell-Harde; M Betts; V Garcia-Martinez; J E Mullersman; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  Chemical mutagenesis of human interferon-beta: construction, expression in E. coli, and biological activity of sodium bisulfite-induced mutations.

Authors:  A G Stewart; J R Adair; G Catlin; C Hynes; J Hall; J Davies; K Dawson; A G Porter
Journal:  DNA       Date:  1987-04

9.  Three-dimensional structure of recombinant human interferon-gamma.

Authors:  S E Ealick; W J Cook; S Vijay-Kumar; M Carson; T L Nagabhushan; P P Trotta; C E Bugg
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

10.  Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma.

Authors:  A Zdanov; C Schalk-Hihi; A Gustchina; M Tsang; J Weatherbee; A Wlodawer
Journal:  Structure       Date:  1995-06-15       Impact factor: 5.006

View more
  51 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking.

Authors:  L C Roisman; J Piehler; J Y Trosset; H A Scheraga; G Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

Authors:  Damian Houde; Steven A Berkowitz; John R Engen
Journal:  J Pharm Sci       Date:  2010-12-29       Impact factor: 3.534

4.  The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling.

Authors:  Zongli Li; Jennifer Julia Strunk; Peter Lamken; Jacob Piehler; Thomas Walz
Journal:  J Mol Biol       Date:  2007-12-08       Impact factor: 5.469

Review 5.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

6.  Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

Authors:  L Runkel; W Meier; R B Pepinsky; M Karpusas; A Whitty; K Kimball; M Brickelmaier; C Muldowney; W Jones; S E Goelz
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

7.  Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.

Authors:  Sebastian A Stifter; Antony Y Matthews; Niamh E Mangan; Ka Yee Fung; Alexander Drew; Michelle D Tate; Tatiana P Soares da Costa; Daniel Hampsey; Jemma Mayall; Phil M Hansbro; Albert Garcia Minambres; Sahar G Eid; Johnson Mak; Judy Scoble; George Lovrecz; Nicole A deWeerd; Paul J Hertzog
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

8.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

9.  Amidation of bioactive peptides: the structure of the lyase domain of the amidating enzyme.

Authors:  Eduardo E Chufán; Mithu De; Betty A Eipper; Richard E Mains; L Mario Amzel
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

10.  Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity.

Authors:  Riccardo Torosantucci; Victor S Sharov; Miranda van Beers; Vera Brinks; Christian Schöneich; Wim Jiskoot
Journal:  Mol Pharm       Date:  2013-05-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.